|
OMIM |
Link |
Information gain |
01 |
|
MVP
|
[NCBI]
|
0.00126235
|
|
|
MENOQ1
|
[NCBI]
|
0.00116078
|
|
|
VRNI
|
[NCBI]
|
0.00105928
|
|
|
KLK3
|
[NCBI]
|
0.00102639
|
|
|
MCKD1
|
[NCBI]
|
0.000764109
|
|
|
deafness, progressive high-tone neural
|
[NCBI]
|
0.000740757
|
|
|
iris pattern
|
[NCBI]
|
0.00068372
|
|
|
hyperpigmentation of eyelids
|
[NCBI]
|
0.00068372
|
|
|
body mass index quantitative trait locus on chromosome 20, in children
|
[NCBI]
|
0.00068372
|
|
|
mammographic density
|
[NCBI]
|
0.00068372
|
|
|
myopathy, distal, with onset in infancy
|
[NCBI]
|
0.00068372
|
|
|
MENAQ1
|
[NCBI]
|
0.00068372
|
|
|
amyotrophic lateral sclerosis, juvenile, with dementia
|
[NCBI]
|
0.00068372
|
|
|
body mass index quantitative trait locus on chromosome 16, in children
|
[NCBI]
|
0.00068372
|
|
|
PCD
|
[NCBI]
|
0.000625914
|
|
|
MDD
|
[NCBI]
|
0.000616093
|
|
|
acrodysostosis
|
[NCBI]
|
0.000594154
|
|
|
nephrolithiasis, calcium oxalate
|
[NCBI]
|
0.000594154
|
|
|
CGF
|
[NCBI]
|
0.000540104
|
|
|
CMM
|
[NCBI]
|
0.000529569
|
|
|
MAFD2
|
[NCBI]
|
0.00052687
|
|
|
APOE
|
[NCBI]
|
0.000457185
|
|
|
primary lateral sclerosis, adult
|
[NCBI]
|
0.000423934
|
|
|
osteoarthropathy of fingers, familial
|
[NCBI]
|
0.000423934
|
|
|
nail dysplasia
|
[NCBI]
|
0.000423934
|
|
|
CACD
|
[NCBI]
|
0.000423934
|
|
|
diabetes mellitus, noninsulin-dependent, 4
|
[NCBI]
|
0.000423934
|
|
|
asparagus, specific smell hypersensitivity
|
[NCBI]
|
0.000423934
|
|
|
nevus flammeus of nape of neck
|
[NCBI]
|
0.000423934
|
|
|
aneurysm, intracranial berry, 3
|
[NCBI]
|
0.000423934
|
|
|
VMD1
|
[NCBI]
|
0.000423934
|
|
|
sjogren syndrome
|
[NCBI]
|
0.000419191
|
|
|
AD
|
[NCBI]
|
0.000399593
|
|
|
DYT2
|
[NCBI]
|
0.000388023
|
|
|
r binder deficiency with lactoferrin deficiency
|
[NCBI]
|
0.00032926
|
|
|
transient erythroblastopenia of childhood
|
[NCBI]
|
0.00032926
|
|
|
OPA2
|
[NCBI]
|
0.00032926
|
|
|
ATFB1
|
[NCBI]
|
0.00032926
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.00032926
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
0.00032926
|
|
|
STUT1
|
[NCBI]
|
0.00032926
|
|
|
wilms tumor 4
|
[NCBI]
|
0.00032926
|
|
|
astigmatism
|
[NCBI]
|
0.00032926
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.00032926
|
|
|
cataract, age-related cortical
|
[NCBI]
|
0.00032926
|
|
|
HD
|
[NCBI]
|
0.000317625
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
0.00031217
|
|
|
PAND1
|
[NCBI]
|
0.000311785
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
0.000311785
|
|
|
IDDM
|
[NCBI]
|
0.000307076
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000283352
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
0.000269684
|
|
|
spondyloenchondrodysplasia
|
[NCBI]
|
0.000269684
|
|
|
MPD2
|
[NCBI]
|
0.000269684
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.000269684
|
|
|
SCAR2
|
[NCBI]
|
0.000269684
|
|
|
PPPP
|
[NCBI]
|
0.000269684
|
|
|
carnosinemia
|
[NCBI]
|
0.000269684
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.000269684
|
|
|
laryngeal abductor paralysis
|
[NCBI]
|
0.000269684
|
|
|
PPR
|
[NCBI]
|
0.000256199
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000253636
|
|
|
IGAN1
|
[NCBI]
|
0.000253636
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000237159
|
|
|
spinal muscular atrophy, childhood, proximal, autosomal dominant
|
[NCBI]
|
0.000226777
|
|
|
FECD2
|
[NCBI]
|
0.000226777
|
|
|
torus palatinus and torus mandibularis
|
[NCBI]
|
0.000226777
|
|
|
GLC1C
|
[NCBI]
|
0.000226777
|
|
|
BZX
|
[NCBI]
|
0.000226777
|
|
|
splenic hypoplasia
|
[NCBI]
|
0.000226777
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.000226777
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000226777
|
|
|
ETM2
|
[NCBI]
|
0.000226777
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000226777
|
|
|
parkinsonism with alveolar hypoventilation and mental depression
|
[NCBI]
|
0.000226777
|
|
|
letterer-siwe disease
|
[NCBI]
|
0.000226777
|
|
|
SHBG
|
[NCBI]
|
0.000226357
|
|
|
SRS
|
[NCBI]
|
0.00022479
|
|
|
VUR1
|
[NCBI]
|
0.000221869
|
|
|
breast cancer
|
[NCBI]
|
0.000205586
|
|
|
CHAT
|
[NCBI]
|
0.000202063
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
0.000193689
|
|
|
jejunal atresia
|
[NCBI]
|
0.000193689
|
|
|
precocious puberty
|
[NCBI]
|
0.000193689
|
|
|
vestibulopathy, familial
|
[NCBI]
|
0.000193689
|
|
|
SCZD10
|
[NCBI]
|
0.000193689
|
|
|
actinic prurigo
|
[NCBI]
|
0.000193689
|
|
|
STHAG4
|
[NCBI]
|
0.000193689
|
|
|
EOCA
|
[NCBI]
|
0.000193689
|
|
|
HMN7A
|
[NCBI]
|
0.000193689
|
|
|
CLN4A
|
[NCBI]
|
0.000193689
|
|
|
kyphomelic dysplasia
|
[NCBI]
|
0.000193689
|
|
|
visceral myopathy, familial, with external ophthalmoplegia
|
[NCBI]
|
0.000193689
|
|
|
BDNF
|
[NCBI]
|
0.000189393
|
|
|
ETM1
|
[NCBI]
|
0.000187915
|
|
|
TNF
|
[NCBI]
|
0.000170908
|
|
|
maxillonasal dysplasia, binder type
|
[NCBI]
|
0.000167088
|
|
|
ECA1
|
[NCBI]
|
0.000167088
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
0.000167088
|
|
|
beta-aminoisobutyric acid, urinary excretion of
|
[NCBI]
|
0.000167088
|
|
|
HMN1
|
[NCBI]
|
0.000167088
|
|
|
cluster headache, familial
|
[NCBI]
|
0.000167088
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000167088
|
|
|
IS1
|
[NCBI]
|
0.000164712
|
|
|
CRC
|
[NCBI]
|
0.000163599
|
|
|
MEN2A
|
[NCBI]
|
0.000159578
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
0.000159513
|
|
|
glycogen storage disease ii
|
[NCBI]
|
0.000149875
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000149307
|
|
|
earlobe crease
|
[NCBI]
|
0.000149263
|
|
|
strabismus, susceptibility to
|
[NCBI]
|
0.000145099
|
|
|
CTS1
|
[NCBI]
|
0.000145099
|
|
|
skin creases, multiple benign ring-shaped, of limbs
|
[NCBI]
|
0.000145099
|
|
|
DFN2
|
[NCBI]
|
0.000145099
|
|
|
RCD1
|
[NCBI]
|
0.000145099
|
|
|
neutropenia, chronic familial
|
[NCBI]
|
0.000145099
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000145099
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.000136003
|
|
|
GFAP
|
[NCBI]
|
0.000130594
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
0.000126557
|
|
|
CDB2
|
[NCBI]
|
0.000126557
|
|
|
IGES
|
[NCBI]
|
0.000126557
|
|
|
NF2
|
[NCBI]
|
0.000124069
|
|
|
palatopharyngeal incompetence
|
[NCBI]
|
0.000122193
|
|
|
RA
|
[NCBI]
|
0.000121177
|
|
|
centralopathic epilepsy
|
[NCBI]
|
0.000110693
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000110693
|
|
|
HPCX
|
[NCBI]
|
0.000110693
|
|
|
musical perfect pitch
|
[NCBI]
|
0.000109014
|
|
|
EGF
|
[NCBI]
|
0.000106977
|
|
|
pernicious anemia
|
[NCBI]
|
0.000106
|
|
|
MODY
|
[NCBI]
|
9.97903e-05
|
|
|
MAFD6
|
[NCBI]
|
9.91056e-05
|
|
|
aortic valve disease
|
[NCBI]
|
9.90857e-05
|
|
|
WDM
|
[NCBI]
|
9.69662e-05
|
|
|
OTSC1
|
[NCBI]
|
9.69662e-05
|
|
|
alzheimer disease 6
|
[NCBI]
|
9.69662e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
9.58626e-05
|
|
|
MG
|
[NCBI]
|
9.58097e-05
|
|
|
BWS
|
[NCBI]
|
9.33527e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
8.92718e-05
|
|
|
nephrotic syndrome, early-onset, with diffuse mesangial sclerosis
|
[NCBI]
|
8.92718e-05
|
|
|
resting heart rate
|
[NCBI]
|
8.92718e-05
|
|
|
MTC
|
[NCBI]
|
8.54233e-05
|
|
|
ETL2
|
[NCBI]
|
8.49878e-05
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
8.49878e-05
|
|
|
HP
|
[NCBI]
|
8.37021e-05
|
|
|
XFS
|
[NCBI]
|
8.04836e-05
|
|
|
FA
|
[NCBI]
|
7.96976e-05
|
|
|
FSHMD1A
|
[NCBI]
|
7.94518e-05
|
|
|
NGFB
|
[NCBI]
|
7.79877e-05
|
|
|
FCDT
|
[NCBI]
|
7.79645e-05
|
|
|
cd4/cd8 t-cell ratio
|
[NCBI]
|
7.79645e-05
|
|
|
carney triad
|
[NCBI]
|
7.79645e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
7.79645e-05
|
|
|
POAG
|
[NCBI]
|
7.7038e-05
|
|
|
MODY1
|
[NCBI]
|
7.6008e-05
|
|
|
ARMD1
|
[NCBI]
|
7.55775e-05
|
|
|
ACHE
|
[NCBI]
|
7.49566e-05
|
|
|
FEB1
|
[NCBI]
|
7.4465e-05
|
|
|
OD
|
[NCBI]
|
7.4465e-05
|
|
|
mesothelioma, malignant
|
[NCBI]
|
7.4465e-05
|
|
|
IDDM4
|
[NCBI]
|
7.4465e-05
|
|
|
hemoglobin, high oxygen saturation of
|
[NCBI]
|
7.18423e-05
|
|
|
mycosis fungoides
|
[NCBI]
|
7.18423e-05
|
|
|
folate level in erythrocytes
|
[NCBI]
|
7.18423e-05
|
|
|
motion sickness
|
[NCBI]
|
7.18423e-05
|
|
|
angiolipomatosis, familial
|
[NCBI]
|
7.18423e-05
|
|
|
BOE
|
[NCBI]
|
7.18423e-05
|
|
|
necrotizing encephalomyelopathy, subacute, of leigh, adult
|
[NCBI]
|
7.18423e-05
|
|
|
normokalemic periodic paralysis
|
[NCBI]
|
7.18423e-05
|
|
|
CMH2
|
[NCBI]
|
7.18423e-05
|
|
|
tibia vara
|
[NCBI]
|
7.18423e-05
|
|
|
low density lipoprotein, variation in molecular weight of
|
[NCBI]
|
7.18423e-05
|
|
|
dicarboxylicamino aciduria
|
[NCBI]
|
7.18423e-05
|
|
|
porokeratosis plantaris, palmaris, et disseminata
|
[NCBI]
|
7.18423e-05
|
|
|
phenformin 4-hydroxylation
|
[NCBI]
|
7.18423e-05
|
|
|
PGP1
|
[NCBI]
|
7.18423e-05
|
|
|
muscular atrophy, malignant neurogenic
|
[NCBI]
|
7.18423e-05
|
|
|
ackerman syndrome
|
[NCBI]
|
7.18423e-05
|
|
|
leishmaniasis, tegumentary
|
[NCBI]
|
7.18423e-05
|
|
|
DHFR
|
[NCBI]
|
6.77176e-05
|
|
|
OMP
|
[NCBI]
|
6.35646e-05
|
|
|
SPMM
|
[NCBI]
|
6.26047e-05
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
6.26047e-05
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
6.26047e-05
|
|
|
BL
|
[NCBI]
|
5.78805e-05
|
|
|
TRS
|
[NCBI]
|
5.69407e-05
|
|
|
vitiligo
|
[NCBI]
|
5.69407e-05
|
|
|
CCAL2
|
[NCBI]
|
5.31323e-05
|
|
|
lactase persistence
|
[NCBI]
|
5.20602e-05
|
|
|
TSD
|
[NCBI]
|
5.18931e-05
|
|
|
klippel-trenaunay-weber syndrome
|
[NCBI]
|
5.08241e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
5.06833e-05
|
|
|
TH
|
[NCBI]
|
5.00135e-05
|
|
|
PSORS1
|
[NCBI]
|
4.99874e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
4.83783e-05
|
|
|
CLN1
|
[NCBI]
|
4.83783e-05
|
|
|
GBD1
|
[NCBI]
|
4.79417e-05
|
|
|
HCHWAD
|
[NCBI]
|
4.79417e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
4.72413e-05
|
|
|
GCKR
|
[NCBI]
|
4.70091e-05
|
|
|
EKD1
|
[NCBI]
|
4.68077e-05
|
|
|
VEGF
|
[NCBI]
|
4.67564e-05
|
|
|
PTH
|
[NCBI]
|
4.62247e-05
|
|
|
CRMO
|
[NCBI]
|
4.6204e-05
|
|
|
AMH
|
[NCBI]
|
4.61677e-05
|
|
|
DGS
|
[NCBI]
|
4.60045e-05
|
|
|
PGR
|
[NCBI]
|
4.57018e-05
|
|
|
wilson disease
|
[NCBI]
|
4.48298e-05
|
|
|
ARMD3
|
[NCBI]
|
4.46313e-05
|
|
|
torticollis
|
[NCBI]
|
4.46313e-05
|
|
|
acrogeria, gottron type
|
[NCBI]
|
4.46313e-05
|
|
|
osteogenesis imperfecta with opalescent teeth
|
[NCBI]
|
4.46313e-05
|
|
|
pulmonary hypertension, primary, autosomal recessive
|
[NCBI]
|
4.46313e-05
|
|
|
hyperostosis frontalis interna
|
[NCBI]
|
4.46313e-05
|
|
|
geographic tongue and fissured tongue
|
[NCBI]
|
4.46313e-05
|
|
|
coarctation of aorta
|
[NCBI]
|
4.46313e-05
|
|
|
muscular dystrophy, scapulohumeral
|
[NCBI]
|
4.46313e-05
|
|
|
paralysis agitans, juvenile, of hunt
|
[NCBI]
|
4.46313e-05
|
|
|
magnesium, elevated red cell
|
[NCBI]
|
4.46313e-05
|
|
|
chorea, benign familial
|
[NCBI]
|
4.46313e-05
|
|
|
IRID1
|
[NCBI]
|
4.42669e-05
|
|
|
PFHB1A
|
[NCBI]
|
4.42669e-05
|
|
|
IRID2
|
[NCBI]
|
4.42669e-05
|
|
|
HSAN3
|
[NCBI]
|
4.41606e-05
|
|
|
NEM3
|
[NCBI]
|
4.41492e-05
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
4.30898e-05
|
|
|
FRDA
|
[NCBI]
|
4.2895e-05
|
|
|
MTTR
|
[NCBI]
|
4.25028e-05
|
|
|
HGF
|
[NCBI]
|
4.16598e-05
|
|
|
SLC18A3
|
[NCBI]
|
4.11531e-05
|
|
|
CCK
|
[NCBI]
|
4.105e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
4.09989e-05
|
|
|
osteoporosis, juvenile
|
[NCBI]
|
4.09989e-05
|
|
|
CLN5
|
[NCBI]
|
4.09989e-05
|
|
|
SPP1
|
[NCBI]
|
3.94245e-05
|
|
|
CF
|
[NCBI]
|
3.91413e-05
|
|
|
HFE
|
[NCBI]
|
3.81272e-05
|
|
|
CDGG1
|
[NCBI]
|
3.80663e-05
|
|
|
AFP
|
[NCBI]
|
3.77932e-05
|
|
|
autism
|
[NCBI]
|
3.6982e-05
|
|
|
alzheimer disease 3
|
[NCBI]
|
3.69408e-05
|
|
|
ARMD4
|
[NCBI]
|
3.54148e-05
|
|
|
gm1-gangliosidosis, type iii
|
[NCBI]
|
3.54148e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
3.53545e-05
|
|
|
NRCLP1
|
[NCBI]
|
3.53545e-05
|
|
|
STL1
|
[NCBI]
|
3.53545e-05
|
|
|
PRL
|
[NCBI]
|
3.52842e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
3.51643e-05
|
|
|
DRPLA
|
[NCBI]
|
3.50176e-05
|
|
|
spastic ataxia
|
[NCBI]
|
3.47111e-05
|
|
|
arcus corneae
|
[NCBI]
|
3.47111e-05
|
|
|
mydriatic response to pharmacologic agents
|
[NCBI]
|
3.47111e-05
|
|
|
macular dystrophy, concentric annular
|
[NCBI]
|
3.47111e-05
|
|
|
fundus dystrophy, pseudoinflammatory, recessive form
|
[NCBI]
|
3.47111e-05
|
|
|
MODY8
|
[NCBI]
|
3.47111e-05
|
|
|
mass syndrome
|
[NCBI]
|
3.47111e-05
|
|
|
bernard-soulier syndrome, benign autosomal dominant
|
[NCBI]
|
3.47111e-05
|
|
|
retinitis pigmentosa, late-adult onset
|
[NCBI]
|
3.47111e-05
|
|
|
NEK1
|
[NCBI]
|
3.47111e-05
|
|
|
thymoma, familial
|
[NCBI]
|
3.47111e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
3.47111e-05
|
|
|
glutamate monosodium sensitivity
|
[NCBI]
|
3.47111e-05
|
|
|
muscular dystrophy, hemizygous lethal type
|
[NCBI]
|
3.47111e-05
|
|
|
PD
|
[NCBI]
|
3.42699e-05
|
|
|
GCK
|
[NCBI]
|
3.37384e-05
|
|
|
ADLTE
|
[NCBI]
|
3.30026e-05
|
|
|
BHC
|
[NCBI]
|
3.30026e-05
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
3.30026e-05
|
|
|
SCA1
|
[NCBI]
|
3.28477e-05
|
|
|
FMF
|
[NCBI]
|
3.2278e-05
|
|
|
VDR
|
[NCBI]
|
3.20942e-05
|
|
|
NF1
|
[NCBI]
|
3.13264e-05
|
|
|
CD
|
[NCBI]
|
3.12532e-05
|
|
|
SPG3A
|
[NCBI]
|
3.10217e-05
|
|
|
SMA1
|
[NCBI]
|
3.06216e-05
|
|
|
NPC1
|
[NCBI]
|
2.89056e-05
|
|
|
temporal arteritis
|
[NCBI]
|
2.86342e-05
|
|
|
methane production
|
[NCBI]
|
2.84663e-05
|
|
|
larynx, congenital partial atresia of
|
[NCBI]
|
2.84663e-05
|
|
|
australia antigen
|
[NCBI]
|
2.84663e-05
|
|
|
OPTA1
|
[NCBI]
|
2.84663e-05
|
|
|
respiratory underresponsiveness to hypoxia and hypercapnia
|
[NCBI]
|
2.84663e-05
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
2.84663e-05
|
|
|
ascaris lumbricoides infection, susceptibility to
|
[NCBI]
|
2.84663e-05
|
|
|
TBDN
|
[NCBI]
|
2.84663e-05
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
2.84663e-05
|
|
|
varicose veins
|
[NCBI]
|
2.84663e-05
|
|
|
sarcoidosis, early-onset
|
[NCBI]
|
2.84663e-05
|
|
|
roussy-levy hereditary areflexic dystasia
|
[NCBI]
|
2.84663e-05
|
|
|
paroxysmal tonic upgaze, benign childhood, with ataxia
|
[NCBI]
|
2.84663e-05
|
|
|
bilirubin, elevated concentrations of, in serum
|
[NCBI]
|
2.84663e-05
|
|
|
hyperlysinemia
|
[NCBI]
|
2.84663e-05
|
|
|
MCDR1
|
[NCBI]
|
2.74505e-05
|
|
|
SMA3
|
[NCBI]
|
2.72379e-05
|
|
|
SOX12
|
[NCBI]
|
2.68981e-05
|
|
|
FOXN4
|
[NCBI]
|
2.68981e-05
|
|
|
HSCR1
|
[NCBI]
|
2.6636e-05
|
|
|
LFS1
|
[NCBI]
|
2.60821e-05
|
|
|
PRNP
|
[NCBI]
|
2.53395e-05
|
|
|
GLC1A
|
[NCBI]
|
2.49741e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
2.3967e-05
|
|
|
JAE
|
[NCBI]
|
2.3967e-05
|
|
|
n-acetylglutamate synthase deficiency
|
[NCBI]
|
2.3967e-05
|
|
|
hypotension, orthostatic
|
[NCBI]
|
2.3967e-05
|
|
|
lichen planus, familial
|
[NCBI]
|
2.3967e-05
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
2.3967e-05
|
|
|
cardiac conduction defect
|
[NCBI]
|
2.3967e-05
|
|
|
metaphyseal chondrodysplasia, jansen type
|
[NCBI]
|
2.3967e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
2.3967e-05
|
|
|
cystinosis, adult nonnephropathic
|
[NCBI]
|
2.3967e-05
|
|
|
novelty seeking personality trait
|
[NCBI]
|
2.3967e-05
|
|
|
CVG/MR
|
[NCBI]
|
2.3967e-05
|
|
|
melanoma-pancreatic cancer syndrome
|
[NCBI]
|
2.3967e-05
|
|
|
EIG
|
[NCBI]
|
2.39403e-05
|
|
|
PROS1
|
[NCBI]
|
2.38836e-05
|
|
|
LAM
|
[NCBI]
|
2.38111e-05
|
|
|
MEN1
|
[NCBI]
|
2.35664e-05
|
|
|
LKS
|
[NCBI]
|
2.28913e-05
|
|
|
HEMB
|
[NCBI]
|
2.25122e-05
|
|
|
CPI
|
[NCBI]
|
2.18458e-05
|
|
|
RB1
|
[NCBI]
|
2.14966e-05
|
|
|
HDL2
|
[NCBI]
|
2.04959e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
2.04959e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
2.04959e-05
|
|
|
HCA2
|
[NCBI]
|
2.04959e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
2.04959e-05
|
|
|
corneal dystrophy, epithelial basement membrane
|
[NCBI]
|
2.04959e-05
|
|
|
DFNA1
|
[NCBI]
|
2.04959e-05
|
|
|
UL
|
[NCBI]
|
2.04959e-05
|
|
|
creatine phosphokinase, elevated serum
|
[NCBI]
|
2.04959e-05
|
|
|
DFNA20
|
[NCBI]
|
2.04959e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.0459e-05
|
|
|
ITGA2
|
[NCBI]
|
2.04195e-05
|
|
|
glycogen storage disease i
|
[NCBI]
|
2.01181e-05
|
|
|
GTS
|
[NCBI]
|
1.96997e-05
|
|
|
dubowitz syndrome
|
[NCBI]
|
1.96566e-05
|
|
|
menkes disease
|
[NCBI]
|
1.92934e-05
|
|
|
MAFD1
|
[NCBI]
|
1.90811e-05
|
|
|
ALB
|
[NCBI]
|
1.89881e-05
|
|
|
dad1-related gene
|
[NCBI]
|
1.87155e-05
|
|
|
FETUB
|
[NCBI]
|
1.87155e-05
|
|
|
UHMK1
|
[NCBI]
|
1.87155e-05
|
|
|
BHLHB4
|
[NCBI]
|
1.87155e-05
|
|
|
BCL2L2
|
[NCBI]
|
1.87155e-05
|
|
|
ETNK1
|
[NCBI]
|
1.87155e-05
|
|
|
GLDN
|
[NCBI]
|
1.87155e-05
|
|
|
SLOS
|
[NCBI]
|
1.82264e-05
|
|
|
LIP
|
[NCBI]
|
1.8154e-05
|
|
|
alcohol dependence
|
[NCBI]
|
1.8154e-05
|
|
|
osteoporosis
|
[NCBI]
|
1.8154e-05
|
|
|
ADRB1
|
[NCBI]
|
1.814e-05
|
|
|
PJS
|
[NCBI]
|
1.79106e-05
|
|
|
GRIA1
|
[NCBI]
|
1.78579e-05
|
|
|
ectodermal dysplasia, anhidrotic
|
[NCBI]
|
1.77041e-05
|
|
|
body mass index
|
[NCBI]
|
1.77041e-05
|
|
|
DSAP1
|
[NCBI]
|
1.77041e-05
|
|
|
CSNB1B
|
[NCBI]
|
1.77041e-05
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
1.77041e-05
|
|
|
aplastic anemia
|
[NCBI]
|
1.77041e-05
|
|
|
floating-harbor syndrome
|
[NCBI]
|
1.77041e-05
|
|
|
pneumothorax, primary spontaneous
|
[NCBI]
|
1.77041e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.72838e-05
|
|
|
TTR
|
[NCBI]
|
1.71508e-05
|
|
|
PDB
|
[NCBI]
|
1.70104e-05
|
|
|
CTGF
|
[NCBI]
|
1.70097e-05
|
|
|
CFTR
|
[NCBI]
|
1.68737e-05
|
|
|
RELN
|
[NCBI]
|
1.68622e-05
|
|
|
CMT1B
|
[NCBI]
|
1.67849e-05
|
|
|
neuroblastoma
|
[NCBI]
|
1.67849e-05
|
|
|
GDNF
|
[NCBI]
|
1.66816e-05
|
|
|
GHRH
|
[NCBI]
|
1.65214e-05
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
1.60405e-05
|
|
|
pheochromocytoma
|
[NCBI]
|
1.59366e-05
|
|
|
SMA2
|
[NCBI]
|
1.59366e-05
|
|
|
lung cancer
|
[NCBI]
|
1.59366e-05
|
|
|
HS1BP3
|
[NCBI]
|
1.56676e-05
|
|
|
PACSIN2
|
[NCBI]
|
1.56676e-05
|
|
|
AGTPBP1
|
[NCBI]
|
1.56676e-05
|
|
|
C1ORF36
|
[NCBI]
|
1.56676e-05
|
|
|
SMC1B
|
[NCBI]
|
1.56676e-05
|
|
|
MLL2
|
[NCBI]
|
1.56676e-05
|
|
|
SEMA5B
|
[NCBI]
|
1.56676e-05
|
|
|
PPARA
|
[NCBI]
|
1.55529e-05
|
|
|
ADHD
|
[NCBI]
|
1.54661e-05
|
|
|
CHED2
|
[NCBI]
|
1.53951e-05
|
|
|
FANCB
|
[NCBI]
|
1.53951e-05
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
1.53951e-05
|
|
|
ear wax, wet/dry
|
[NCBI]
|
1.53951e-05
|
|
|
ehlers-danlos syndrome, type iii
|
[NCBI]
|
1.53951e-05
|
|
|
deafness, aminoglycoside-induced
|
[NCBI]
|
1.53951e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
1.53951e-05
|
|
|
IDD
|
[NCBI]
|
1.53951e-05
|
|
|
IBMPFD
|
[NCBI]
|
1.53951e-05
|
|
|
AMDM
|
[NCBI]
|
1.53951e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
1.53951e-05
|
|
|
obesity
|
[NCBI]
|
1.53239e-05
|
|
|
OPMD
|
[NCBI]
|
1.5049e-05
|
|
|
SELP
|
[NCBI]
|
1.47373e-05
|
|
|
SLC18A2
|
[NCBI]
|
1.42885e-05
|
|
|
AIS
|
[NCBI]
|
1.42483e-05
|
|
|
ICA1
|
[NCBI]
|
1.3711e-05
|
|
|
PTPRS
|
[NCBI]
|
1.3711e-05
|
|
|
FEZF2
|
[NCBI]
|
1.3711e-05
|
|
|
FAIM2
|
[NCBI]
|
1.3711e-05
|
|
|
GPD1L
|
[NCBI]
|
1.3711e-05
|
|
|
PRMT3
|
[NCBI]
|
1.3711e-05
|
|
|
CFHR3
|
[NCBI]
|
1.3711e-05
|
|
|
CPEB1
|
[NCBI]
|
1.3711e-05
|
|
|
PRSS8
|
[NCBI]
|
1.3711e-05
|
|
|
UBC
|
[NCBI]
|
1.3711e-05
|
|
|
POU6F2
|
[NCBI]
|
1.3711e-05
|
|
|
OPTA2
|
[NCBI]
|
1.34471e-05
|
|
|
PLSJ
|
[NCBI]
|
1.34471e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
1.34471e-05
|
|
|
caffey disease
|
[NCBI]
|
1.34471e-05
|
|
|
INAD1
|
[NCBI]
|
1.34471e-05
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
1.34471e-05
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
1.34471e-05
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
1.34471e-05
|
|
|
IS
|
[NCBI]
|
1.34471e-05
|
|
|
HES
|
[NCBI]
|
1.34471e-05
|
|
|
mitochondrial myopathy
|
[NCBI]
|
1.34471e-05
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
1.30819e-05
|
|
|
testicular tumors
|
[NCBI]
|
1.30819e-05
|
|
|
RBP3
|
[NCBI]
|
1.30085e-05
|
|
|
ACP5
|
[NCBI]
|
1.29403e-05
|
|
|
CD
|
[NCBI]
|
1.29263e-05
|
|
|
EGFR
|
[NCBI]
|
1.29144e-05
|
|
|
GPD1
|
[NCBI]
|
1.22728e-05
|
|
|
EDG2
|
[NCBI]
|
1.22728e-05
|
|
|
CHI3L1
|
[NCBI]
|
1.22728e-05
|
|
|
TSTA3
|
[NCBI]
|
1.22728e-05
|
|
|
SIM1
|
[NCBI]
|
1.22728e-05
|
|
|
ACLY
|
[NCBI]
|
1.22728e-05
|
|
|
EFEMP1
|
[NCBI]
|
1.22728e-05
|
|
|
CPB1
|
[NCBI]
|
1.22728e-05
|
|
|
DMTF1
|
[NCBI]
|
1.22728e-05
|
|
|
ELA1
|
[NCBI]
|
1.22728e-05
|
|
|
MEF2D
|
[NCBI]
|
1.22728e-05
|
|
|
PG
|
[NCBI]
|
1.22657e-05
|
|
|
COMP
|
[NCBI]
|
1.22597e-05
|
|
|
homocysteinemia
|
[NCBI]
|
1.22381e-05
|
|
|
NPPA
|
[NCBI]
|
1.21902e-05
|
|
|
PTK2
|
[NCBI]
|
1.20757e-05
|
|
|
FRAP1
|
[NCBI]
|
1.20705e-05
|
|
|
HBB
|
[NCBI]
|
1.20006e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.19523e-05
|
|
|
AVP
|
[NCBI]
|
1.18893e-05
|
|
|
SCN3
|
[NCBI]
|
1.17794e-05
|
|
|
alzheimer disease 4
|
[NCBI]
|
1.17794e-05
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
1.17794e-05
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
1.17794e-05
|
|
|
WZS
|
[NCBI]
|
1.17794e-05
|
|
|
muenke syndrome
|
[NCBI]
|
1.17794e-05
|
|
|
MUC1
|
[NCBI]
|
1.16415e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.13768e-05
|
|
|
RBP1
|
[NCBI]
|
1.13689e-05
|
|
|
IRS2
|
[NCBI]
|
1.12399e-05
|
|
|
MJD
|
[NCBI]
|
1.11572e-05
|
|
|
GFRA2
|
[NCBI]
|
1.11399e-05
|
|
|
LHX9
|
[NCBI]
|
1.11399e-05
|
|
|
HMCN1
|
[NCBI]
|
1.11399e-05
|
|
|
GCSH
|
[NCBI]
|
1.11399e-05
|
|
|
SRG1
|
[NCBI]
|
1.11399e-05
|
|
|
SLC16A7
|
[NCBI]
|
1.11399e-05
|
|
|
ARNT2
|
[NCBI]
|
1.11399e-05
|
|
|
GJB4
|
[NCBI]
|
1.11399e-05
|
|
|
POU4F1
|
[NCBI]
|
1.11399e-05
|
|
|
ST8SIA1
|
[NCBI]
|
1.11399e-05
|
|
|
SOX5
|
[NCBI]
|
1.11399e-05
|
|
|
OLIG1
|
[NCBI]
|
1.11399e-05
|
|
|
KIF11
|
[NCBI]
|
1.11399e-05
|
|
|
NIPA1
|
[NCBI]
|
1.11399e-05
|
|
|
PFTK1
|
[NCBI]
|
1.11399e-05
|
|
|
BIK
|
[NCBI]
|
1.11399e-05
|
|
|
GRIK2
|
[NCBI]
|
1.11399e-05
|
|
|
PSEN1
|
[NCBI]
|
1.10299e-05
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
1.0927e-05
|
|
|
SLC40A1
|
[NCBI]
|
1.0927e-05
|
|
|
gastric cancer
|
[NCBI]
|
1.06905e-05
|
|
|
FCHL
|
[NCBI]
|
1.06905e-05
|
|
|
PENK
|
[NCBI]
|
1.06238e-05
|
|
|
SMAX1
|
[NCBI]
|
1.05956e-05
|
|
|
ACH
|
[NCBI]
|
1.04735e-05
|
|
|
COMT
|
[NCBI]
|
1.03504e-05
|
|
|
MODY3
|
[NCBI]
|
1.03356e-05
|
|
|
ATS
|
[NCBI]
|
1.03356e-05
|
|
|
SPG6
|
[NCBI]
|
1.03356e-05
|
|
|
galactokinase deficiency
|
[NCBI]
|
1.03356e-05
|
|
|
LGMD1A
|
[NCBI]
|
1.03356e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
1.03356e-05
|
|
|
IFD
|
[NCBI]
|
1.03356e-05
|
|
|
PHA1
|
[NCBI]
|
1.03356e-05
|
|
|
scheie syndrome
|
[NCBI]
|
1.03356e-05
|
|
|
gracile syndrome
|
[NCBI]
|
1.03356e-05
|
|
|
CMT2A2
|
[NCBI]
|
1.03356e-05
|
|
|
CNGA2
|
[NCBI]
|
1.02088e-05
|
|
|
PMX1
|
[NCBI]
|
1.02088e-05
|
|
|
PPARGC1B
|
[NCBI]
|
1.02088e-05
|
|
|
FBLN5
|
[NCBI]
|
1.02088e-05
|
|
|
MIA
|
[NCBI]
|
1.02088e-05
|
|
|
HOXB4
|
[NCBI]
|
1.02088e-05
|
|
|
PPP1R3A
|
[NCBI]
|
1.02088e-05
|
|
|
BRCA1
|
[NCBI]
|
9.95637e-06
|
|
|
MAS
|
[NCBI]
|
9.82561e-06
|
|
|
PMD
|
[NCBI]
|
9.78058e-06
|
|
|
APOA1
|
[NCBI]
|
9.75846e-06
|
|
|
STAT3
|
[NCBI]
|
9.60143e-06
|
|
|
PWS
|
[NCBI]
|
9.4905e-06
|
|
|
WAS
|
[NCBI]
|
9.44095e-06
|
|
|
SLC11A2
|
[NCBI]
|
9.4337e-06
|
|
|
PDE10A
|
[NCBI]
|
9.42101e-06
|
|
|
TST
|
[NCBI]
|
9.42101e-06
|
|
|
VTN
|
[NCBI]
|
9.42101e-06
|
|
|
CHIT1
|
[NCBI]
|
9.42101e-06
|
|
|
CHRNG
|
[NCBI]
|
9.42101e-06
|
|
|
tl antigen
|
[NCBI]
|
9.42101e-06
|
|
|
INHBB
|
[NCBI]
|
9.42101e-06
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
9.42101e-06
|
|
|
POU3F1
|
[NCBI]
|
9.42101e-06
|
|
|
GNRH1
|
[NCBI]
|
9.38951e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
9.30117e-06
|
|
|
SNCA
|
[NCBI]
|
9.27559e-06
|
|
|
ASPA
|
[NCBI]
|
9.27188e-06
|
|
|
LTA
|
[NCBI]
|
9.27188e-06
|
|
|
HRG
|
[NCBI]
|
9.12024e-06
|
|
|
HFM
|
[NCBI]
|
9.08665e-06
|
|
|
DFNA6
|
[NCBI]
|
9.0747e-06
|
|
|
SFD
|
[NCBI]
|
9.0747e-06
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
9.0747e-06
|
|
|
ALUNC
|
[NCBI]
|
9.0747e-06
|
|
|
sarcoidosis
|
[NCBI]
|
9.0747e-06
|
|
|
CMT4A
|
[NCBI]
|
9.0747e-06
|
|
|
SMDP1
|
[NCBI]
|
9.0747e-06
|
|
|
methylmalonic aciduria and homocystinuria, cblc type
|
[NCBI]
|
9.0747e-06
|
|
|
IHPS1
|
[NCBI]
|
9.0747e-06
|
|
|
acheiropody
|
[NCBI]
|
9.0747e-06
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
9.0747e-06
|
|
|
renal cysts and diabetes syndrome
|
[NCBI]
|
9.0747e-06
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
9.0747e-06
|
|
|
XPF
|
[NCBI]
|
9.0747e-06
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
9.04251e-06
|
|
|
prostate cancer
|
[NCBI]
|
8.99121e-06
|
|
|
HBFQTL2
|
[NCBI]
|
8.79636e-06
|
|
|
PDYN
|
[NCBI]
|
8.79149e-06
|
|
|
GAMT
|
[NCBI]
|
8.79149e-06
|
|
|
FGF19
|
[NCBI]
|
8.74044e-06
|
|
|
ABCG8
|
[NCBI]
|
8.74044e-06
|
|
|
CCKBR
|
[NCBI]
|
8.74044e-06
|
|
|
EDNRA
|
[NCBI]
|
8.74044e-06
|
|
|
CFHR1
|
[NCBI]
|
8.74044e-06
|
|
|
SEMA5A
|
[NCBI]
|
8.74044e-06
|
|
|
HDAC9
|
[NCBI]
|
8.74044e-06
|
|
|
NOTCH4
|
[NCBI]
|
8.74044e-06
|
|
|
GSTZ1
|
[NCBI]
|
8.74044e-06
|
|
|
HBQ1
|
[NCBI]
|
8.74044e-06
|
|
|
DAB1
|
[NCBI]
|
8.74044e-06
|
|
|
BRCA2
|
[NCBI]
|
8.71017e-06
|
|
|
OCA2
|
[NCBI]
|
8.67655e-06
|
|
|
PCTT
|
[NCBI]
|
8.67655e-06
|
|
|
TYMS
|
[NCBI]
|
8.65903e-06
|
|
|
WRN
|
[NCBI]
|
8.63421e-06
|
|
|
MYH11
|
[NCBI]
|
8.56266e-06
|
|
|
LCAT
|
[NCBI]
|
8.29905e-06
|
|
|
PMCH
|
[NCBI]
|
8.29905e-06
|
|
|
ACPP
|
[NCBI]
|
8.25325e-06
|
|
|
NRP2
|
[NCBI]
|
8.14308e-06
|
|
|
APOA5
|
[NCBI]
|
8.14308e-06
|
|
|
SLC5A6
|
[NCBI]
|
8.14308e-06
|
|
|
NES
|
[NCBI]
|
8.14308e-06
|
|
|
CTSG
|
[NCBI]
|
8.14308e-06
|
|
|
EYA2
|
[NCBI]
|
8.14308e-06
|
|
|
AMT
|
[NCBI]
|
8.14308e-06
|
|
|
FSTL1
|
[NCBI]
|
8.14308e-06
|
|
|
PABPN1
|
[NCBI]
|
8.14308e-06
|
|
|
SLC30A3
|
[NCBI]
|
8.14308e-06
|
|
|
HGPS
|
[NCBI]
|
8.09588e-06
|
|
|
SVAS
|
[NCBI]
|
8.09588e-06
|
|
|
gaucher disease, type i
|
[NCBI]
|
8.09588e-06
|
|
|
CMTX1
|
[NCBI]
|
8.0776e-06
|
|
|
CP
|
[NCBI]
|
8.02433e-06
|
|
|
alzheimer disease 2
|
[NCBI]
|
7.96619e-06
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
7.96619e-06
|
|
|
crouzon syndrome
|
[NCBI]
|
7.96619e-06
|
|
|
CMT2A1
|
[NCBI]
|
7.96619e-06
|
|
|
WS2A
|
[NCBI]
|
7.96619e-06
|
|
|
autoimmune disease
|
[NCBI]
|
7.96619e-06
|
|
|
cutis laxa, autosomal recessive, type i
|
[NCBI]
|
7.96619e-06
|
|
|
ALS2
|
[NCBI]
|
7.96619e-06
|
|
|
amyloidosis v
|
[NCBI]
|
7.96619e-06
|
|
|
septooptic dysplasia
|
[NCBI]
|
7.96619e-06
|
|
|
LRP1
|
[NCBI]
|
7.82604e-06
|
|
|
NS1
|
[NCBI]
|
7.71436e-06
|
|
|
LBP
|
[NCBI]
|
7.7046e-06
|
|
|
F3
|
[NCBI]
|
7.62917e-06
|
|
|
RTN1
|
[NCBI]
|
7.6122e-06
|
|
|
ZMPSTE24
|
[NCBI]
|
7.6122e-06
|
|
|
TREM2
|
[NCBI]
|
7.6122e-06
|
|
|
HOXA1
|
[NCBI]
|
7.6122e-06
|
|
|
PAX7
|
[NCBI]
|
7.6122e-06
|
|
|
MYT1
|
[NCBI]
|
7.6122e-06
|
|
|
SGCB
|
[NCBI]
|
7.6122e-06
|
|
|
HK2
|
[NCBI]
|
7.6122e-06
|
|
|
NID
|
[NCBI]
|
7.6122e-06
|
|
|
PON1
|
[NCBI]
|
7.46366e-06
|
|
|
PF4
|
[NCBI]
|
7.42457e-06
|
|
|
AT
|
[NCBI]
|
7.37046e-06
|
|
|
BGLAP
|
[NCBI]
|
7.36733e-06
|
|
|
SLC6A4
|
[NCBI]
|
7.27336e-06
|
|
|
APCS
|
[NCBI]
|
7.14201e-06
|
|
|
KRT17
|
[NCBI]
|
7.13565e-06
|
|
|
GNPAT
|
[NCBI]
|
7.13565e-06
|
|
|
RYR3
|
[NCBI]
|
7.13565e-06
|
|
|
TTPA
|
[NCBI]
|
7.13565e-06
|
|
|
MECP2
|
[NCBI]
|
7.08479e-06
|
|
|
APOB
|
[NCBI]
|
7.062e-06
|
|
|
LGMD2I
|
[NCBI]
|
6.98653e-06
|
|
|
BHD
|
[NCBI]
|
6.98653e-06
|
|
|
sitosterolemia
|
[NCBI]
|
6.98653e-06
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
6.98653e-06
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
6.98653e-06
|
|
|
WGN1
|
[NCBI]
|
6.98653e-06
|
|
|
tetralogy of fallot
|
[NCBI]
|
6.98653e-06
|
|
|
kaposi sarcoma
|
[NCBI]
|
6.98653e-06
|
|
|
asplenia with cardiovascular anomalies
|
[NCBI]
|
6.98653e-06
|
|
|
JBS
|
[NCBI]
|
6.98653e-06
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
6.97616e-06
|
|
|
aHUS
|
[NCBI]
|
6.97616e-06
|
|
|
CTNS
|
[NCBI]
|
6.97616e-06
|
|
|
CDLS1
|
[NCBI]
|
6.95188e-06
|
|
|
SOD1
|
[NCBI]
|
6.85777e-06
|
|
|
LEPR
|
[NCBI]
|
6.84396e-06
|
|
|
SALL4
|
[NCBI]
|
6.70435e-06
|
|
|
DLGAP1
|
[NCBI]
|
6.70435e-06
|
|
|
OLIG2
|
[NCBI]
|
6.70435e-06
|
|
|
GNAQ
|
[NCBI]
|
6.70435e-06
|
|
|
SIRT2
|
[NCBI]
|
6.70435e-06
|
|
|
XDH
|
[NCBI]
|
6.66469e-06
|
|
|
CMT1A
|
[NCBI]
|
6.49845e-06
|
|
|
isoniazid inactivation
|
[NCBI]
|
6.44963e-06
|
|
|
ABCC1
|
[NCBI]
|
6.33285e-06
|
|
|
ACTG1
|
[NCBI]
|
6.3113e-06
|
|
|
CSPG5
|
[NCBI]
|
6.3113e-06
|
|
|
OLR1
|
[NCBI]
|
6.3113e-06
|
|
|
AQP7
|
[NCBI]
|
6.3113e-06
|
|
|
PDE4D
|
[NCBI]
|
6.3113e-06
|
|
|
FH
|
[NCBI]
|
6.28799e-06
|
|
|
IDE
|
[NCBI]
|
6.28528e-06
|
|
|
APC
|
[NCBI]
|
6.24435e-06
|
|
|
VIM
|
[NCBI]
|
6.17868e-06
|
|
|
RLBP1
|
[NCBI]
|
6.13059e-06
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
6.11726e-06
|
|
|
lipoid congenital adrenal hyperplasia
|
[NCBI]
|
6.11726e-06
|
|
|
MCPH1
|
[NCBI]
|
6.11726e-06
|
|
|
CFTD
|
[NCBI]
|
6.11726e-06
|
|
|
JH
|
[NCBI]
|
6.11726e-06
|
|
|
myasthenic syndrome, congenital, associated with episodic apnea
|
[NCBI]
|
6.11726e-06
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
6.11726e-06
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
6.11726e-06
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
6.11726e-06
|
|
|
DSCR1
|
[NCBI]
|
5.95104e-06
|
|
|
OGG1
|
[NCBI]
|
5.95104e-06
|
|
|
PRPH
|
[NCBI]
|
5.95104e-06
|
|
|
LU
|
[NCBI]
|
5.95104e-06
|
|
|
SCN2A
|
[NCBI]
|
5.95104e-06
|
|
|
HABP2
|
[NCBI]
|
5.95104e-06
|
|
|
PI
|
[NCBI]
|
5.93693e-06
|
|
|
MPO
|
[NCBI]
|
5.88768e-06
|
|
|
CPB2
|
[NCBI]
|
5.86857e-06
|
|
|
phenylketonuria
|
[NCBI]
|
5.82218e-06
|
|
|
AVSD
|
[NCBI]
|
5.78843e-06
|
|
|
ALS1
|
[NCBI]
|
5.78843e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
5.75966e-06
|
|
|
MBP
|
[NCBI]
|
5.72145e-06
|
|
|
PLP1
|
[NCBI]
|
5.68231e-06
|
|
|
KSS
|
[NCBI]
|
5.67945e-06
|
|
|
SIX5
|
[NCBI]
|
5.61917e-06
|
|
|
TBX21
|
[NCBI]
|
5.61917e-06
|
|
|
LOR
|
[NCBI]
|
5.61917e-06
|
|
|
PFC
|
[NCBI]
|
5.61917e-06
|
|
|
CTNS
|
[NCBI]
|
5.61917e-06
|
|
|
PLAU
|
[NCBI]
|
5.61917e-06
|
|
|
EFNB2
|
[NCBI]
|
5.61917e-06
|
|
|
HEPH
|
[NCBI]
|
5.61917e-06
|
|
|
NTRK3
|
[NCBI]
|
5.61917e-06
|
|
|
DRD2
|
[NCBI]
|
5.54039e-06
|
|
|
PSEN2
|
[NCBI]
|
5.54039e-06
|
|
|
BMD
|
[NCBI]
|
5.54032e-06
|
|
|
IGER
|
[NCBI]
|
5.54032e-06
|
|
|
TLR4
|
[NCBI]
|
5.38817e-06
|
|
|
IAPP
|
[NCBI]
|
5.37731e-06
|
|
|
ASPS
|
[NCBI]
|
5.34364e-06
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
5.34364e-06
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
5.34364e-06
|
|
|
PPAC
|
[NCBI]
|
5.34364e-06
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
5.34364e-06
|
|
|
GCE
|
[NCBI]
|
5.34364e-06
|
|
|
GSD
|
[NCBI]
|
5.34364e-06
|
|
|
VED
|
[NCBI]
|
5.34364e-06
|
|
|
alexander disease
|
[NCBI]
|
5.34364e-06
|
|
|
PANK2
|
[NCBI]
|
5.31215e-06
|
|
|
MC3R
|
[NCBI]
|
5.31215e-06
|
|
|
TXNIP
|
[NCBI]
|
5.31215e-06
|
|
|
THBD
|
[NCBI]
|
5.31215e-06
|
|
|
ELAC2
|
[NCBI]
|
5.31215e-06
|
|
|
BAK1
|
[NCBI]
|
5.31215e-06
|
|
|
TLR1
|
[NCBI]
|
5.31215e-06
|
|
|
BEST1
|
[NCBI]
|
5.31215e-06
|
|
|
CYBA
|
[NCBI]
|
5.31215e-06
|
|
|
asthma, susceptibility to
|
[NCBI]
|
5.15087e-06
|
|
|
CRX
|
[NCBI]
|
5.02704e-06
|
|
|
ATXN7
|
[NCBI]
|
5.02704e-06
|
|
|
NR5A2
|
[NCBI]
|
5.02704e-06
|
|
|
SCNN1A
|
[NCBI]
|
5.02704e-06
|
|
|
DNMT3A
|
[NCBI]
|
5.02704e-06
|
|
|
GCG
|
[NCBI]
|
5.02704e-06
|
|
|
PEG3
|
[NCBI]
|
5.02704e-06
|
|
|
FGB
|
[NCBI]
|
5.02704e-06
|
|
|
PKD2
|
[NCBI]
|
5.00694e-06
|
|
|
HNF4A
|
[NCBI]
|
5.00694e-06
|
|
|
TFPI
|
[NCBI]
|
4.9353e-06
|
|
|
RTT
|
[NCBI]
|
4.92017e-06
|
|
|
BCHE
|
[NCBI]
|
4.85638e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
4.82451e-06
|
|
|
HLF
|
[NCBI]
|
4.7614e-06
|
|
|
TCRD
|
[NCBI]
|
4.7614e-06
|
|
|
GLDC
|
[NCBI]
|
4.7614e-06
|
|
|
SREBF1
|
[NCBI]
|
4.7614e-06
|
|
|
TCF3
|
[NCBI]
|
4.7614e-06
|
|
|
VMD
|
[NCBI]
|
4.71081e-06
|
|
|
DYT3
|
[NCBI]
|
4.65367e-06
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
4.65367e-06
|
|
|
FXTAS
|
[NCBI]
|
4.65367e-06
|
|
|
diabetes-deafness syndrome, maternally transmitted
|
[NCBI]
|
4.65367e-06
|
|
|
EVR1
|
[NCBI]
|
4.65367e-06
|
|
|
longevity
|
[NCBI]
|
4.65367e-06
|
|
|
DHRD
|
[NCBI]
|
4.65367e-06
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
4.65367e-06
|
|
|
NPM1
|
[NCBI]
|
4.59386e-06
|
|
|
CFH
|
[NCBI]
|
4.59386e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
4.52862e-06
|
|
|
FGF9
|
[NCBI]
|
4.51319e-06
|
|
|
PCDH15
|
[NCBI]
|
4.51319e-06
|
|
|
SLC1A1
|
[NCBI]
|
4.51319e-06
|
|
|
FUT2
|
[NCBI]
|
4.51319e-06
|
|
|
APRT
|
[NCBI]
|
4.50655e-06
|
|
|
AKR1B1
|
[NCBI]
|
4.50655e-06
|
|
|
EV
|
[NCBI]
|
4.42657e-06
|
|
|
EDMD
|
[NCBI]
|
4.33072e-06
|
|
|
SLC6A3
|
[NCBI]
|
4.31652e-06
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
4.28065e-06
|
|
|
SN
|
[NCBI]
|
4.28065e-06
|
|
|
HAP1
|
[NCBI]
|
4.28065e-06
|
|
|
GALK1
|
[NCBI]
|
4.28065e-06
|
|
|
TMOD
|
[NCBI]
|
4.28065e-06
|
|
|
NNMT
|
[NCBI]
|
4.28065e-06
|
|
|
NCSTN
|
[NCBI]
|
4.28065e-06
|
|
|
PGD
|
[NCBI]
|
4.28065e-06
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
4.24483e-06
|
|
|
BCR
|
[NCBI]
|
4.23503e-06
|
|
|
GIST
|
[NCBI]
|
4.13925e-06
|
|
|
DSPP
|
[NCBI]
|
4.08314e-06
|
|
|
EPHB2
|
[NCBI]
|
4.06229e-06
|
|
|
GJB6
|
[NCBI]
|
4.06229e-06
|
|
|
DRD3
|
[NCBI]
|
4.06229e-06
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
4.0375e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
4.0375e-06
|
|
|
glycogen storage disease iv
|
[NCBI]
|
4.0375e-06
|
|
|
MNS
|
[NCBI]
|
4.0375e-06
|
|
|
FBS
|
[NCBI]
|
4.0375e-06
|
|
|
bladder cancer
|
[NCBI]
|
4.0375e-06
|
|
|
DYT1
|
[NCBI]
|
3.97234e-06
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
3.87578e-06
|
|
|
DLK1
|
[NCBI]
|
3.85683e-06
|
|
|
CYCS
|
[NCBI]
|
3.85683e-06
|
|
|
GHRHR
|
[NCBI]
|
3.85683e-06
|
|
|
HLA-DQB1
|
[NCBI]
|
3.85683e-06
|
|
|
ASIP
|
[NCBI]
|
3.85683e-06
|
|
|
JUN
|
[NCBI]
|
3.85683e-06
|
|
|
FUS
|
[NCBI]
|
3.85683e-06
|
|
|
MBL2
|
[NCBI]
|
3.83918e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
3.80334e-06
|
|
|
DRD4
|
[NCBI]
|
3.77892e-06
|
|
|
MC4R
|
[NCBI]
|
3.77892e-06
|
|
|
VAMP2
|
[NCBI]
|
3.66314e-06
|
|
|
AACT
|
[NCBI]
|
3.66314e-06
|
|
|
TCOF1
|
[NCBI]
|
3.66314e-06
|
|
|
RHD
|
[NCBI]
|
3.66314e-06
|
|
|
GJB3
|
[NCBI]
|
3.66314e-06
|
|
|
EEF2
|
[NCBI]
|
3.66314e-06
|
|
|
LAMB3
|
[NCBI]
|
3.66314e-06
|
|
|
DLD
|
[NCBI]
|
3.66314e-06
|
|
|
CRIP1
|
[NCBI]
|
3.66314e-06
|
|
|
LTC4S
|
[NCBI]
|
3.66314e-06
|
|
|
SLC5A7
|
[NCBI]
|
3.66314e-06
|
|
|
IP
|
[NCBI]
|
3.65698e-06
|
|
|
TF
|
[NCBI]
|
3.65366e-06
|
|
|
CHH
|
[NCBI]
|
3.63555e-06
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
3.63467e-06
|
|
|
SCA6
|
[NCBI]
|
3.63467e-06
|
|
|
LRRK2
|
[NCBI]
|
3.58738e-06
|
|
|
TNFSF6
|
[NCBI]
|
3.52083e-06
|
|
|
TPO
|
[NCBI]
|
3.50381e-06
|
|
|
ARSA
|
[NCBI]
|
3.49482e-06
|
|
|
CLN2
|
[NCBI]
|
3.48692e-06
|
|
|
HNA
|
[NCBI]
|
3.48692e-06
|
|
|
pancreatic carcinoma
|
[NCBI]
|
3.48692e-06
|
|
|
MFN2
|
[NCBI]
|
3.48023e-06
|
|
|
IRF1
|
[NCBI]
|
3.48023e-06
|
|
|
CDH23
|
[NCBI]
|
3.48023e-06
|
|
|
ACOX1
|
[NCBI]
|
3.48023e-06
|
|
|
CASP1
|
[NCBI]
|
3.48023e-06
|
|
|
FGF7
|
[NCBI]
|
3.47468e-06
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
3.31682e-06
|
|
|
PIAS1
|
[NCBI]
|
3.30725e-06
|
|
|
HK1
|
[NCBI]
|
3.30725e-06
|
|
|
HLA-DRB1
|
[NCBI]
|
3.30725e-06
|
|
|
MYH9
|
[NCBI]
|
3.30725e-06
|
|
|
JAK2
|
[NCBI]
|
3.27911e-06
|
|
|
KCNH2
|
[NCBI]
|
3.27911e-06
|
|
|
ALK
|
[NCBI]
|
3.26941e-06
|
|
|
FGF8
|
[NCBI]
|
3.22928e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
3.18089e-06
|
|
|
LYZ
|
[NCBI]
|
3.14343e-06
|
|
|
GALC
|
[NCBI]
|
3.14343e-06
|
|
|
MAPK7
|
[NCBI]
|
3.14343e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.1171e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
3.01792e-06
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
2.99502e-06
|
|
|
SCA10
|
[NCBI]
|
2.99502e-06
|
|
|
DA2A
|
[NCBI]
|
2.99502e-06
|
|
|
PLOSL
|
[NCBI]
|
2.99502e-06
|
|
|
MEN2B
|
[NCBI]
|
2.99502e-06
|
|
|
PPARGC1A
|
[NCBI]
|
2.98809e-06
|
|
|
LRP8
|
[NCBI]
|
2.98809e-06
|
|
|
GSTM1
|
[NCBI]
|
2.98809e-06
|
|
|
RDT
|
[NCBI]
|
2.94742e-06
|
|
|
TCOF
|
[NCBI]
|
2.94742e-06
|
|
|
DBI
|
[NCBI]
|
2.93728e-06
|
|
|
BSG
|
[NCBI]
|
2.90173e-06
|
|
|
SRF
|
[NCBI]
|
2.87478e-06
|
|
|
AHR
|
[NCBI]
|
2.85438e-06
|
|
|
SLC17A7
|
[NCBI]
|
2.84062e-06
|
|
|
MYCN
|
[NCBI]
|
2.84062e-06
|
|
|
DYT1
|
[NCBI]
|
2.84062e-06
|
|
|
TNNT2
|
[NCBI]
|
2.84062e-06
|
|
|
PROP1
|
[NCBI]
|
2.84062e-06
|
|
|
FAAH
|
[NCBI]
|
2.82611e-06
|
|
|
VIP
|
[NCBI]
|
2.74412e-06
|
|
|
HHT
|
[NCBI]
|
2.73718e-06
|
|
|
TCRB
|
[NCBI]
|
2.70049e-06
|
|
|
FABP2
|
[NCBI]
|
2.70049e-06
|
|
|
HLA-DQA1
|
[NCBI]
|
2.70049e-06
|
|
|
ASS
|
[NCBI]
|
2.67437e-06
|
|
|
DMD
|
[NCBI]
|
2.64291e-06
|
|
|
MS
|
[NCBI]
|
2.61684e-06
|
|
|
NCOA2
|
[NCBI]
|
2.5672e-06
|
|
|
PBP
|
[NCBI]
|
2.5672e-06
|
|
|
ADK
|
[NCBI]
|
2.5672e-06
|
|
|
DHH
|
[NCBI]
|
2.5672e-06
|
|
|
NOS2A
|
[NCBI]
|
2.5672e-06
|
|
|
MB
|
[NCBI]
|
2.56455e-06
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
2.55591e-06
|
|
|
histidinemia
|
[NCBI]
|
2.55591e-06
|
|
|
LCT
|
[NCBI]
|
2.53091e-06
|
|
|
STAR
|
[NCBI]
|
2.46675e-06
|
|
|
PMP22
|
[NCBI]
|
2.46321e-06
|
|
|
UCP3
|
[NCBI]
|
2.4615e-06
|
|
|
COL4A5
|
[NCBI]
|
2.44031e-06
|
|
|
RBP4
|
[NCBI]
|
2.44031e-06
|
|
|
MSH6
|
[NCBI]
|
2.44031e-06
|
|
|
AQP3
|
[NCBI]
|
2.44031e-06
|
|
|
STAT4
|
[NCBI]
|
2.44031e-06
|
|
|
E2F1
|
[NCBI]
|
2.44031e-06
|
|
|
PRODH
|
[NCBI]
|
2.44031e-06
|
|
|
GRP
|
[NCBI]
|
2.4277e-06
|
|
|
EPOR
|
[NCBI]
|
2.4277e-06
|
|
|
PYY
|
[NCBI]
|
2.41865e-06
|
|
|
PXE
|
[NCBI]
|
2.36494e-06
|
|
|
PEDF
|
[NCBI]
|
2.35713e-06
|
|
|
CAT
|
[NCBI]
|
2.33718e-06
|
|
|
GCH1
|
[NCBI]
|
2.31942e-06
|
|
|
CETP
|
[NCBI]
|
2.31942e-06
|
|
|
SCA7
|
[NCBI]
|
2.22723e-06
|
|
|
WS1
|
[NCBI]
|
2.22723e-06
|
|
|
MTND6
|
[NCBI]
|
2.20417e-06
|
|
|
TERC
|
[NCBI]
|
2.20417e-06
|
|
|
MTND5
|
[NCBI]
|
2.20417e-06
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
2.16458e-06
|
|
|
PLG
|
[NCBI]
|
2.13166e-06
|
|
|
GJB2
|
[NCBI]
|
2.115e-06
|
|
|
SLS
|
[NCBI]
|
2.11309e-06
|
|
|
CLCN1
|
[NCBI]
|
2.09422e-06
|
|
|
CYBB
|
[NCBI]
|
2.09422e-06
|
|
|
CFI
|
[NCBI]
|
2.09422e-06
|
|
|
IL5
|
[NCBI]
|
2.09422e-06
|
|
|
SOX10
|
[NCBI]
|
2.09422e-06
|
|
|
DNAJC5
|
[NCBI]
|
2.09422e-06
|
|
|
GRPR
|
[NCBI]
|
2.09422e-06
|
|
|
ARPKD
|
[NCBI]
|
1.99666e-06
|
|
|
NPY
|
[NCBI]
|
1.99469e-06
|
|
|
GLB1
|
[NCBI]
|
1.98927e-06
|
|
|
GSN
|
[NCBI]
|
1.98927e-06
|
|
|
MTTK
|
[NCBI]
|
1.98927e-06
|
|
|
PEPD
|
[NCBI]
|
1.98927e-06
|
|
|
GPI
|
[NCBI]
|
1.94189e-06
|
|
|
CHM
|
[NCBI]
|
1.92081e-06
|
|
|
GHRL
|
[NCBI]
|
1.88905e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.88905e-06
|
|
|
MSD
|
[NCBI]
|
1.81666e-06
|
|
|
MLC
|
[NCBI]
|
1.81666e-06
|
|
|
EKV
|
[NCBI]
|
1.81666e-06
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
1.81666e-06
|
|
|
sudden infant death syndrome
|
[NCBI]
|
1.81666e-06
|
|
|
DRD
|
[NCBI]
|
1.81666e-06
|
|
|
TGD
|
[NCBI]
|
1.81666e-06
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
1.81666e-06
|
|
|
NGB
|
[NCBI]
|
1.7933e-06
|
|
|
NR6A1
|
[NCBI]
|
1.7933e-06
|
|
|
coproporphyria
|
[NCBI]
|
1.7933e-06
|
|
|
NTRK2
|
[NCBI]
|
1.7933e-06
|
|
|
GATA1
|
[NCBI]
|
1.7933e-06
|
|
|
SPS
|
[NCBI]
|
1.78949e-06
|
|
|
RCC1
|
[NCBI]
|
1.7815e-06
|
|
|
EPO
|
[NCBI]
|
1.76969e-06
|
|
|
DNMT1
|
[NCBI]
|
1.71878e-06
|
|
|
krabbe disease
|
[NCBI]
|
1.71045e-06
|
|
|
MTCO1
|
[NCBI]
|
1.70178e-06
|
|
|
BGN
|
[NCBI]
|
1.70178e-06
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
1.68662e-06
|
|
|
GH1
|
[NCBI]
|
1.68488e-06
|
|
|
hemophilia a
|
[NCBI]
|
1.65526e-06
|
|
|
LMNA
|
[NCBI]
|
1.63384e-06
|
|
|
HDGF
|
[NCBI]
|
1.61428e-06
|
|
|
RS1
|
[NCBI]
|
1.61428e-06
|
|
|
ADRB2
|
[NCBI]
|
1.61428e-06
|
|
|
hurler syndrome
|
[NCBI]
|
1.58118e-06
|
|
|
apc gene
|
[NCBI]
|
1.56136e-06
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
1.55754e-06
|
|
|
SLC1A2
|
[NCBI]
|
1.53059e-06
|
|
|
HNMT
|
[NCBI]
|
1.53059e-06
|
|
|
PPT1
|
[NCBI]
|
1.53059e-06
|
|
|
C4B
|
[NCBI]
|
1.53059e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.53059e-06
|
|
|
biotinidase deficiency
|
[NCBI]
|
1.50838e-06
|
|
|
CMM2
|
[NCBI]
|
1.50838e-06
|
|
|
glycogen storage disease v
|
[NCBI]
|
1.50838e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
1.50838e-06
|
|
|
ABCG2
|
[NCBI]
|
1.5063e-06
|
|
|
ALD
|
[NCBI]
|
1.48204e-06
|
|
|
ATP7B
|
[NCBI]
|
1.45053e-06
|
|
|
fucosidosis
|
[NCBI]
|
1.45053e-06
|
|
|
APP
|
[NCBI]
|
1.43528e-06
|
|
|
MAP2
|
[NCBI]
|
1.41491e-06
|
|
|
ABP1
|
[NCBI]
|
1.37894e-06
|
|
|
GAA
|
[NCBI]
|
1.37392e-06
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
1.37392e-06
|
|
|
PCNA
|
[NCBI]
|
1.35817e-06
|
|
|
WT1
|
[NCBI]
|
1.32015e-06
|
|
|
TCRG
|
[NCBI]
|
1.30062e-06
|
|
|
MMP3
|
[NCBI]
|
1.30062e-06
|
|
|
ACADM
|
[NCBI]
|
1.29053e-06
|
|
|
PLTP
|
[NCBI]
|
1.29053e-06
|
|
|
TP53
|
[NCBI]
|
1.27569e-06
|
|
|
SERPINA6
|
[NCBI]
|
1.24122e-06
|
|
|
thiourea tasting
|
[NCBI]
|
1.23644e-06
|
|
|
gaucher disease, type iii
|
[NCBI]
|
1.23644e-06
|
|
|
ODDD
|
[NCBI]
|
1.23644e-06
|
|
|
SEDC
|
[NCBI]
|
1.23644e-06
|
|
|
SOCS1
|
[NCBI]
|
1.23045e-06
|
|
|
BRAF
|
[NCBI]
|
1.23045e-06
|
|
|
ADIPOQ
|
[NCBI]
|
1.23045e-06
|
|
|
maple syrup urine disease
|
[NCBI]
|
1.22455e-06
|
|
|
CCM
|
[NCBI]
|
1.22455e-06
|
|
|
HHF2
|
[NCBI]
|
1.22455e-06
|
|
|
PC
|
[NCBI]
|
1.22255e-06
|
|
|
MCP
|
[NCBI]
|
1.20408e-06
|
|
|
FGFR3
|
[NCBI]
|
1.16334e-06
|
|
|
ENG
|
[NCBI]
|
1.1633e-06
|
|
|
FBN1
|
[NCBI]
|
1.14206e-06
|
|
|
IL6
|
[NCBI]
|
1.11966e-06
|
|
|
APS1
|
[NCBI]
|
1.11314e-06
|
|
|
KAL1
|
[NCBI]
|
1.09902e-06
|
|
|
IL2RA
|
[NCBI]
|
1.09902e-06
|
|
|
PDCD8
|
[NCBI]
|
1.09855e-06
|
|
|
fabry disease
|
[NCBI]
|
1.08401e-06
|
|
|
down syndrome
|
[NCBI]
|
1.07017e-06
|
|
|
LQT1
|
[NCBI]
|
1.06384e-06
|
|
|
PTEN
|
[NCBI]
|
1.03734e-06
|
|
|
AS
|
[NCBI]
|
1.02782e-06
|
|
|
VASP
|
[NCBI]
|
1.01039e-06
|
|
|
DYX1
|
[NCBI]
|
9.97925e-07
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
9.97925e-07
|
|
|
RP
|
[NCBI]
|
9.92195e-07
|
|
|
ABCA1
|
[NCBI]
|
9.78596e-07
|
|
|
factor x deficiency
|
[NCBI]
|
9.78596e-07
|
|
|
DMPK
|
[NCBI]
|
9.78596e-07
|
|
|
ERBB2
|
[NCBI]
|
9.78596e-07
|
|
|
TCF7L2
|
[NCBI]
|
9.78596e-07
|
|
|
IFNG
|
[NCBI]
|
9.78596e-07
|
|
|
TNFRSF6
|
[NCBI]
|
9.78596e-07
|
|
|
TSC1
|
[NCBI]
|
9.78596e-07
|
|
|
PAM
|
[NCBI]
|
9.56579e-07
|
|
|
SOD2
|
[NCBI]
|
9.3711e-07
|
|
|
ABCB1
|
[NCBI]
|
9.3101e-07
|
|
|
galactosemia
|
[NCBI]
|
9.24323e-07
|
|
|
LNS
|
[NCBI]
|
9.24323e-07
|
|
|
BRRS
|
[NCBI]
|
9.24323e-07
|
|
|
HBG2
|
[NCBI]
|
9.22236e-07
|
|
|
GIP
|
[NCBI]
|
9.12781e-07
|
|
|
CDK5
|
[NCBI]
|
9.1154e-07
|
|
|
HMBS
|
[NCBI]
|
9.05059e-07
|
|
|
GC
|
[NCBI]
|
8.79367e-07
|
|
|
HCRT
|
[NCBI]
|
8.68305e-07
|
|
|
FGF23
|
[NCBI]
|
8.68305e-07
|
|
|
STAT1
|
[NCBI]
|
8.53938e-07
|
|
|
PKD1
|
[NCBI]
|
8.23423e-07
|
|
|
RP2
|
[NCBI]
|
8.16707e-07
|
|
|
OPTB1
|
[NCBI]
|
7.90265e-07
|
|
|
FHM1
|
[NCBI]
|
7.90265e-07
|
|
|
NPS
|
[NCBI]
|
7.87364e-07
|
|
|
MAP1B
|
[NCBI]
|
7.67354e-07
|
|
|
PVR
|
[NCBI]
|
7.67354e-07
|
|
|
CFB
|
[NCBI]
|
7.2016e-07
|
|
|
MTND1
|
[NCBI]
|
7.2016e-07
|
|
|
CSF3
|
[NCBI]
|
7.2016e-07
|
|
|
SCN5A
|
[NCBI]
|
7.2016e-07
|
|
|
ADCYAP1
|
[NCBI]
|
6.96612e-07
|
|
|
RHO
|
[NCBI]
|
6.83605e-07
|
|
|
DFSP
|
[NCBI]
|
6.3762e-07
|
|
|
LHCGR
|
[NCBI]
|
6.31934e-07
|
|
|
IGFALS
|
[NCBI]
|
6.20234e-07
|
|
|
usher syndrome, type i
|
[NCBI]
|
6.11173e-07
|
|
|
SPDA1
|
[NCBI]
|
6.11173e-07
|
|
|
RNASE3
|
[NCBI]
|
6.0849e-07
|
|
|
DDC
|
[NCBI]
|
5.92638e-07
|
|
|
MSH2
|
[NCBI]
|
5.90756e-07
|
|
|
KIT
|
[NCBI]
|
5.90756e-07
|
|
|
CRH
|
[NCBI]
|
5.57916e-07
|
|
|
GJA1
|
[NCBI]
|
5.56199e-07
|
|
|
PGM1
|
[NCBI]
|
5.51441e-07
|
|
|
NFKB1
|
[NCBI]
|
5.51441e-07
|
|
|
A2M
|
[NCBI]
|
5.51441e-07
|
|
|
NIDDM
|
[NCBI]
|
5.51332e-07
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
5.43116e-07
|
|
|
BCNS
|
[NCBI]
|
5.28236e-07
|
|
|
FGFR1
|
[NCBI]
|
5.27658e-07
|
|
|
RET
|
[NCBI]
|
5.19878e-07
|
|
|
GNRHR
|
[NCBI]
|
5.13927e-07
|
|
|
WBS
|
[NCBI]
|
5.13403e-07
|
|
|
PNPLA6
|
[NCBI]
|
4.96472e-07
|
|
|
SLPI
|
[NCBI]
|
4.96472e-07
|
|
|
PCD
|
[NCBI]
|
4.61709e-07
|
|
|
apert syndrome
|
[NCBI]
|
4.58607e-07
|
|
|
STGD1
|
[NCBI]
|
4.58607e-07
|
|
|
RP1
|
[NCBI]
|
4.58607e-07
|
|
|
porphyria variegata
|
[NCBI]
|
4.52039e-07
|
|
|
TNC
|
[NCBI]
|
4.51609e-07
|
|
|
MAG
|
[NCBI]
|
4.46284e-07
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
4.33825e-07
|
|
|
LDLR
|
[NCBI]
|
4.24892e-07
|
|
|
CDH1
|
[NCBI]
|
4.1159e-07
|
|
|
MMP9
|
[NCBI]
|
4.1159e-07
|
|
|
CDKN2A
|
[NCBI]
|
4.06591e-07
|
|
|
MITF
|
[NCBI]
|
4.06591e-07
|
|
|
ACE
|
[NCBI]
|
3.84446e-07
|
|
|
MTND4
|
[NCBI]
|
3.80696e-07
|
|
|
KLF1
|
[NCBI]
|
3.80696e-07
|
|
|
FMR1
|
[NCBI]
|
3.8036e-07
|
|
|
INS
|
[NCBI]
|
3.76688e-07
|
|
|
CCND1
|
[NCBI]
|
3.69019e-07
|
|
|
NF2
|
[NCBI]
|
3.51325e-07
|
|
|
ITGB3
|
[NCBI]
|
3.51325e-07
|
|
|
MAPT
|
[NCBI]
|
3.50779e-07
|
|
|
GAPDH
|
[NCBI]
|
3.46008e-07
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
3.3656e-07
|
|
|
XPA
|
[NCBI]
|
3.3656e-07
|
|
|
LSA
|
[NCBI]
|
3.30737e-07
|
|
|
MMP2
|
[NCBI]
|
3.23431e-07
|
|
|
LCN2
|
[NCBI]
|
3.23431e-07
|
|
|
CEACAM5
|
[NCBI]
|
3.14149e-07
|
|
|
UCP2
|
[NCBI]
|
2.98318e-07
|
|
|
GJB1
|
[NCBI]
|
2.98318e-07
|
|
|
IRS1
|
[NCBI]
|
2.96966e-07
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
2.8545e-07
|
|
|
PPIA
|
[NCBI]
|
2.81603e-07
|
|
|
SPARC
|
[NCBI]
|
2.7189e-07
|
|
|
ELN
|
[NCBI]
|
2.7189e-07
|
|
|
UCN
|
[NCBI]
|
2.65285e-07
|
|
|
CYP1A1
|
[NCBI]
|
2.54664e-07
|
|
|
BMP4
|
[NCBI]
|
2.4937e-07
|
|
|
ESR1
|
[NCBI]
|
2.4937e-07
|
|
|
SOCS3
|
[NCBI]
|
2.48159e-07
|
|
|
NMU
|
[NCBI]
|
2.48159e-07
|
|
|
LIPC
|
[NCBI]
|
2.48159e-07
|
|
|
TGFB1
|
[NCBI]
|
2.48159e-07
|
|
|
NOTCH1
|
[NCBI]
|
2.48159e-07
|
|
|
CD36
|
[NCBI]
|
2.48159e-07
|
|
|
PPARG
|
[NCBI]
|
2.33866e-07
|
|
|
AGER
|
[NCBI]
|
2.33287e-07
|
|
|
CNTF
|
[NCBI]
|
2.33231e-07
|
|
|
LGMD2C
|
[NCBI]
|
2.25917e-07
|
|
|
FPLD2
|
[NCBI]
|
2.25917e-07
|
|
|
GCCR
|
[NCBI]
|
2.25734e-07
|
|
|
LPL
|
[NCBI]
|
2.22817e-07
|
|
|
COL1A1
|
[NCBI]
|
2.18778e-07
|
|
|
NR5A1
|
[NCBI]
|
2.04577e-07
|
|
|
PLAUR
|
[NCBI]
|
1.89881e-07
|
|
|
VHL
|
[NCBI]
|
1.88814e-07
|
|
|
TFF3
|
[NCBI]
|
1.84653e-07
|
|
|
NGFR
|
[NCBI]
|
1.78333e-07
|
|
|
RSTS
|
[NCBI]
|
1.75886e-07
|
|
|
BLM
|
[NCBI]
|
1.74566e-07
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
1.74566e-07
|
|
|
LS
|
[NCBI]
|
1.74566e-07
|
|
|
GAL
|
[NCBI]
|
1.69109e-07
|
|
|
SLE
|
[NCBI]
|
1.67046e-07
|
|
|
PAX3
|
[NCBI]
|
1.65926e-07
|
|
|
PTHLH
|
[NCBI]
|
1.64736e-07
|
|
|
MAOA
|
[NCBI]
|
1.6274e-07
|
|
|
PCOS1
|
[NCBI]
|
1.55464e-07
|
|
|
IFNA1
|
[NCBI]
|
1.49846e-07
|
|
|
SCZD
|
[NCBI]
|
1.4476e-07
|
|
|
FGF2
|
[NCBI]
|
1.42482e-07
|
|
|
TSC2
|
[NCBI]
|
1.31933e-07
|
|
|
TS
|
[NCBI]
|
1.31552e-07
|
|
|
NR0B2
|
[NCBI]
|
1.16605e-07
|
|
|
LOX
|
[NCBI]
|
1.16605e-07
|
|
|
VCP
|
[NCBI]
|
1.16605e-07
|
|
|
SRC
|
[NCBI]
|
1.13971e-07
|
|
|
MTS
|
[NCBI]
|
1.136e-07
|
|
|
SMEI
|
[NCBI]
|
1.136e-07
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
1.136e-07
|
|
|
CJD
|
[NCBI]
|
1.07359e-07
|
|
|
MYOC
|
[NCBI]
|
1.02977e-07
|
|
|
PIGR
|
[NCBI]
|
1.02977e-07
|
|
|
MVP
|
[NCBI]
|
1.02349e-07
|
|
|
LEP
|
[NCBI]
|
1.01504e-07
|
|
|
FGA
|
[NCBI]
|
8.91364e-08
|
|
|
AR
|
[NCBI]
|
8.89587e-08
|
|
|
GUSB
|
[NCBI]
|
8.24859e-08
|
|
|
costello syndrome
|
[NCBI]
|
7.96156e-08
|
|
|
PARK2
|
[NCBI]
|
7.96156e-08
|
|
|
TG
|
[NCBI]
|
7.81551e-08
|
|
|
XIST
|
[NCBI]
|
7.69413e-08
|
|
|
MLH1
|
[NCBI]
|
7.69413e-08
|
|
|
PARK2
|
[NCBI]
|
7.69413e-08
|
|
|
FTD
|
[NCBI]
|
7.29734e-08
|
|
|
hypertension, essential
|
[NCBI]
|
7.11565e-08
|
|
|
PARP1
|
[NCBI]
|
6.57371e-08
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
6.41686e-08
|
|
|
SHH
|
[NCBI]
|
6.2299e-08
|
|
|
MFS
|
[NCBI]
|
5.54227e-08
|
|
|
CMH
|
[NCBI]
|
4.86033e-08
|
|
|
POMC
|
[NCBI]
|
4.61003e-08
|
|
|
NR1I2
|
[NCBI]
|
3.78063e-08
|
|
|
CML
|
[NCBI]
|
3.55611e-08
|
|
|
SPG4
|
[NCBI]
|
3.55611e-08
|
|
|
HCH
|
[NCBI]
|
3.55611e-08
|
|
|
PTGS2
|
[NCBI]
|
3.36983e-08
|
|
|
DMD
|
[NCBI]
|
3.10386e-08
|
|
|
MTR
|
[NCBI]
|
3.03417e-08
|
|
|
TRPV1
|
[NCBI]
|
3.03417e-08
|
|
|
ARNT
|
[NCBI]
|
3.03417e-08
|
|
|
G6PD
|
[NCBI]
|
2.99475e-08
|
|
|
PDS
|
[NCBI]
|
2.82683e-08
|
|
|
PNMT
|
[NCBI]
|
2.01437e-08
|
|
|
IBD1
|
[NCBI]
|
1.87667e-08
|
|
|
PSACH
|
[NCBI]
|
1.87667e-08
|
|
|
OXT
|
[NCBI]
|
1.77067e-08
|
|
|
CPE
|
[NCBI]
|
1.69606e-08
|
|
|
OPRM1
|
[NCBI]
|
1.25921e-08
|
|
|
HIGM1
|
[NCBI]
|
9.37874e-09
|
|
|
SJS1
|
[NCBI]
|
9.37874e-09
|
|
|
XLP1
|
[NCBI]
|
9.37874e-09
|
|
|
CADASIL
|
[NCBI]
|
9.37874e-09
|
|
|
CLL
|
[NCBI]
|
9.37874e-09
|
|
|
sandhoff disease
|
[NCBI]
|
9.37874e-09
|
|
|
FGF1
|
[NCBI]
|
8.84986e-09
|
|
|
homocystinuria
|
[NCBI]
|
8.84986e-09
|
|
|
ADA
|
[NCBI]
|
8.57406e-09
|
|
|
ATS
|
[NCBI]
|
6.63045e-09
|
|
|
IHH
|
[NCBI]
|
6.59528e-09
|
|
|
MPZ
|
[NCBI]
|
5.74678e-09
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
5.74678e-09
|
|
|
VHL
|
[NCBI]
|
5.64269e-09
|
|
|
CVID
|
[NCBI]
|
2.40931e-09
|
|
|
COL2A1
|
[NCBI]
|
1.51247e-09
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
4.09451e-10
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
4.09451e-10
|
|
|
SCA2
|
[NCBI]
|
9.44732e-11
|
|
|
malaria, susceptibility to
|
[NCBI]
|
4.72131e-11
|
|
|
OPA1
|
[NCBI]
|
4.72131e-11
|
|
|
CLN3
|
[NCBI]
|
4.72131e-11
|
|
|
GHR
|
[NCBI]
|
6.26415e-12
|
|
|
HLA-A
|
[NCBI]
|
2.08657e-12
|
|
|
BTK
|
[NCBI]
|
2.08657e-12
|
|
|
GBA
|
[NCBI]
|
2.08657e-12
|
|